Similarly, our Transwell and wound-healing data revealed that while knockdown of TDRKH-AS1 reduced the invasive capability of BC cells, this response was partially reversed in the presence of the miR-134-5p inhibitor (Fig. 4C, D). This evidence concerns the gene TDRKH and breast cancer.